Does West Virginia Medicaid Cover Wegovy or Zepbound?
West Virginia (WV) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does West Virginia Medicaid cover weight-loss GLP-1s, has West Virginia expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
West Virginia Medicaid GLP-1 coverage: what the state's own documents say
West Virginia Medicaid lists agents used for weight loss as a non-covered service; Wegovy is considered only for secondary cardiovascular prevention or MASH and Zepbound only for moderate-to-severe obstructive sleep apnea. Bills to mandate private-insurance GLP-1 coverage (HB 2912, HB 5153) were not enacted.
Checked September 20, 2026 against: bms.wv.gov, bms.wv.gov, bms.wv.gov.
West Virginia state employee health plan: what the plan's own documents say
The Summary Plan Descriptions for PEIA's 2026 and 2027 plan years list 'Anorexiants (any drug used for the purpose of weight loss)' and weight-control drugs as not covered and state that the GLP-1 class is covered for Type 2 diabetes only. A roughly 1,000-member GLP-1 pilot that began in 2019 was paused on March 15, 2024 because of rising cost.
Checked September 20, 2026 against: peia.wv.gov, peia.wv.gov, wvpublic.org.
Notable insurers active in West Virginia (not independently verified): Highmark Blue Cross Blue Shield, Aetna, UnitedHealthcare.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (West Virginia is not one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the West Virginia-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for West Virginia residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
West Virginia carrier coverage details
National carriers active in West Virginia (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does West Virginia Medicaid cover Wegovy or Zepbound for weight loss?
No. West Virginia Medicaid lists agents used for weight loss as a non-covered service; Wegovy is considered only for secondary cardiovascular prevention or MASH and Zepbound only for moderate-to-severe obstructive sleep apnea. Bills to mandate private-insurance GLP-1 coverage (HB 2912, HB 5153) were not enacted. This was checked against West Virginia's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has West Virginia expanded Medicaid under the ACA?
Yes - West Virginia has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the West Virginia state employee health plan cover Wegovy or Zepbound?
No. The Summary Plan Descriptions for PEIA's 2026 and 2027 plan years list 'Anorexiants (any drug used for the purpose of weight loss)' and weight-control drugs as not covered and state that the GLP-1 class is covered for Type 2 diabetes only. A roughly 1,000-member GLP-1 pilot that began in 2019 was paused on March 15, 2024 because of rising cost. This was checked against West Virginia's own plan documents on September 20, 2026; plan terms are reset each plan year, so confirm with your plan before relying on it.